INCY Insider Transactions — Page 12
2,447 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1,101–1,200; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-12-16 | Sale | 12,000.0 | $72.36 |
| DE SCHUTTER RICHARD U | DirectorOther | 2014-12-02 | Sale | 47,800.0 | $74.87 |
| DE SCHUTTER RICHARD U | DirectorOther | 2014-12-01 | Sale | 2,200.0 | $75.26 |
| Daly James M | EVP, Chief Commercial Officer | 2014-11-24 | Sale | 11,111.0 | $74.08 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-11-17 | Sale | 12,000.0 | $69.97 |
| FRIEDMAN PAUL A | Director | 2014-11-06 | Sale | 185,653.0 | $67.87 |
| Daly James M | EVP, Chief Commercial Officer | 2014-10-23 | Sale | 11,111.0 | $53.49 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-10-16 | Sale | 8,000.0 | $49.03 |
| Daly James M | EVP, Chief Commercial Officer | 2014-09-23 | Sale | 11,111.0 | $47.65 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-09-16 | Sale | 8,000.0 | $47.58 |
| Daly James M | EVP, Chief Commercial Officer | 2014-08-25 | Sale | 11,111.0 | $51.96 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-08-18 | Sale | 8,000.0 | $51.97 |
| Daly James M | EVP, Chief Commercial Officer | 2014-07-23 | Sale | 11,111.0 | $48.54 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-07-16 | Sale | 8,000.0 | $48.15 |
| Daly James M | EVP, Chief Commercial Officer | 2014-06-23 | Sale | 8,334.0 | $55.92 |
| Daly James M | EVP, Chief Commercial Officer | 2014-06-23 | Sale | 2,777.0 | $56.38 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-06-16 | Sale | 8,000.0 | $53.88 |
| HASTINGS DAVID C | Chief Financial Officer | 2014-06-05 | Sale | 123,966.0 | $52.81 |
| HASTINGS DAVID C | Chief Financial Officer | 2014-06-04 | Sale | 76,034.0 | $52.61 |
| Daly James M | EVP, Chief Commercial Officer | 2014-05-23 | Sale | 11,111.0 | $48.48 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-05-16 | Sale | 8,000.0 | $50.68 |
| Chardonnet Laurent | Other | 2014-05-12 | Sale | 2,058.0 | $54.0 |
| Chardonnet Laurent | Other | 2014-05-02 | Sale | 34,000.0 | $51.55 |
| Daly James M | EVP, Chief Commercial Officer | 2014-04-23 | Sale | 30,555.0 | $47.71 |
| FRIEDMAN PAUL A | Director | 2014-02-20 | Sale | 33,354.0 | $63.51 |
| DE SCHUTTER RICHARD U | DirectorOther | 2014-02-19 | Sale | 7,455.0 | $65.5 |
| FRIEDMAN PAUL A | Director | 2014-02-19 | Sale | 40,919.0 | $62.66 |
| DE SCHUTTER RICHARD U | DirectorOther | 2014-02-18 | Sale | 42,545.0 | $65.54 |
| FRIEDMAN PAUL A | Director | 2014-02-18 | Sale | 720,036.0 | $65.82 |
| HASTINGS DAVID C | Chief Financial Officer | 2014-02-18 | Sale | 32,001.0 | $65.64 |
| FRIEDMAN PAUL A | Director | 2014-02-14 | Sale | 10,227.0 | $65.52 |
| HASTINGS DAVID C | Chief Financial Officer | 2014-02-14 | Sale | 40,000.0 | $64.74 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-02-14 | Sale | 39,787.0 | $66.13 |
| ARIKO BARRY A | Director | 2014-02-13 | Sale | 10,000.0 | $66.49 |
| SWAIN PAULA J | EVP, Human Resources | 2014-02-13 | Sale | 216,967.0 | $66.73 |
| Siegel Eric H. | EVP, General Counsel | 2014-02-13 | Sale | 1,187.0 | $66.5 |
| Siegel Eric H. | EVP, General Counsel | 2014-02-13 | Sale | 54,855.0 | $66.67 |
| Chardonnet Laurent | Other | 2014-02-13 | Sale | 98,334.0 | $66.28 |
| HASTINGS DAVID C | Chief Financial Officer | 2014-02-13 | Sale | 202,999.0 | $66.12 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2014-02-13 | Sale | 191,309.0 | $66.38 |
| Daly James M | EVP, Chief Commercial Officer | 2014-02-13 | Sale | 158,331.0 | $66.49 |
| WHITFIELD ROY A | Director | 2013-11-18 | Sale | 50,000.0 | $47.37 |
| FRIEDMAN PAUL A | Chief Executive Officer | 2013-09-10 | Sale | 376,789.0 | $37.32 |
| Chardonnet Laurent | Other | 2013-09-09 | Sale | 36,067.0 | $37.9 |
| HASTINGS DAVID C | Chief Financial Officer | 2013-09-06 | Sale | 100,000.0 | $35.16 |
| Siegel Eric H. | EVP, General Counsel | 2013-09-06 | Sale | 55,978.0 | $35.17 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2013-09-06 | Sale | 25,000.0 | $35.28 |
| Chardonnet Laurent | Other | 2013-09-05 | Sale | 8,767.0 | $34.9 |
| SWAIN PAULA J | EVP, Human Resources | 2013-09-05 | Sale | 94,444.0 | $35.06 |
| WHITFIELD ROY A | Director | 2013-08-19 | Sale | 50,000.0 | $26.7 |
| WHITFIELD ROY A | Director | 2013-05-17 | Sale | 40,000.0 | $23.08 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2013-05-13 | Sale | 55,699.0 | $22.3 |
| WHITFIELD ROY A | Director | 2013-03-14 | Sale | 10,000.0 | $25.08 |
| WHITFIELD ROY A | Director | 2013-03-01 | Sale | 10,000.0 | $22.56 |
| Siegel Eric H. | EVP, General Counsel | 2013-02-28 | Sale | 50,000.0 | $22.16 |
| SWAIN PAULA J | EVP, Human Resources | 2013-02-20 | Sale | 103,283.0 | $21.53 |
| WHITFIELD ROY A | Director | 2013-02-19 | Sale | 30,000.0 | $21.82 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2013-02-15 | Sale | 98,440.0 | $22.48 |
| HASTINGS DAVID C | Chief Financial Officer | 2013-02-15 | Sale | 100,000.0 | $22.52 |
| DE SCHUTTER RICHARD U | DirectorOther | 2012-12-17 | Purchase | 45,000.0 | $16.11 |
| DE SCHUTTER RICHARD U | DirectorOther | 2012-12-17 | Sale | 50,000.0 | $16.03 |
| Chardonnet Laurent | Other | 2012-07-05 | Sale | 600.0 | $25.13 |
| Chardonnet Laurent | Other | 2012-07-05 | Sale | 2,214.0 | $25.12 |
| Chardonnet Laurent | Other | 2012-07-05 | Sale | 27,300.0 | $25.11 |
| Chardonnet Laurent | Other | 2012-07-05 | Sale | 5,586.0 | $25.1 |
| Chardonnet Laurent | Other | 2012-07-02 | Sale | 36,666.0 | $24.15 |
| WHITFIELD ROY A | Director | 2012-05-24 | Sale | 20,000.0 | $22.27 |
| BROOKE PAUL A | Director | 2012-05-16 | Sale | 5,000.0 | $23.55 |
| Siegel Eric H. | EVP, General Counsel | 2012-05-14 | Sale | 715.0 | $23.11 |
| Siegel Eric H. | EVP, General Counsel | 2012-05-14 | Sale | 100.0 | $23.12 |
| Siegel Eric H. | EVP, General Counsel | 2012-05-14 | Sale | 56,666.0 | $23.12 |
| SWAIN PAULA J | EVP, Human Resources | 2012-05-11 | Sale | 147,389.0 | $23.22 |
| FRIEDMAN PAUL A | Chief Executive Officer | 2012-05-07 | Sale | 225,000.0 | $22.56 |
| Chardonnet Laurent | Other | 2012-05-01 | Sale | 13,976.0 | $22.7 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 2012-04-27 | Sale | 30,000.0 | $22.95 |
| WHITFIELD ROY A | Director | 2012-02-17 | Sale | 700.0 | $17.56 |
| WHITFIELD ROY A | Director | 2012-02-17 | Sale | 4,600.0 | $17.55 |
| WHITFIELD ROY A | Director | 2012-02-17 | Sale | 3,600.0 | $17.54 |
| WHITFIELD ROY A | Director | 2012-02-17 | Sale | 7,000.0 | $17.53 |
| WHITFIELD ROY A | Director | 2012-02-17 | Sale | 1,200.0 | $17.52 |
| WHITFIELD ROY A | Director | 2012-02-17 | Sale | 600.0 | $17.51 |
| WHITFIELD ROY A | Director | 2012-02-17 | Sale | 2,300.0 | $17.5 |
| BROOKE PAUL A | Director | 2012-01-19 | Purchase | 25,000.0 | $17.86 |
| BROOKE PAUL A | Director | 2012-01-18 | Purchase | 25,000.0 | $17.53 |
| BAKER JULIAN | Director,TenPercentOwner | 2012-01-13 | Purchase | 1,122.0 | $16.62 |
| BAKER FELIX | Director,TenPercentOwner | 2012-01-13 | Purchase | 1,122.0 | $16.62 |
| 14159 capital (GP), LLC | Director,TenPercentOwner | 2012-01-13 | Purchase | 1,122.0 | $16.62 |
| BAKER JULIAN | Director,TenPercentOwner | 2012-01-13 | Purchase | 1,965.0 | $16.58 |
| BAKER FELIX | Director,TenPercentOwner | 2012-01-13 | Purchase | 1,965.0 | $16.58 |
| 14159 capital (GP), LLC | Director,TenPercentOwner | 2012-01-13 | Purchase | 1,965.0 | $16.58 |
| BAKER JULIAN | Director,TenPercentOwner | 2012-01-13 | Purchase | 2,769.0 | $16.46 |
| BAKER FELIX | Director,TenPercentOwner | 2012-01-13 | Purchase | 2,769.0 | $16.46 |
| 14159 capital (GP), LLC | Director,TenPercentOwner | 2012-01-13 | Purchase | 2,769.0 | $16.46 |
| BAKER JULIAN | Director,TenPercentOwner | 2012-01-13 | Purchase | 41,677.0 | $16.62 |
| BAKER FELIX | Director,TenPercentOwner | 2012-01-13 | Purchase | 41,677.0 | $16.62 |
| Baker Brothers Life Sciences Capital (GP), LLC | Director,TenPercentOwner | 2012-01-13 | Purchase | 41,677.0 | $16.62 |
| BAKER JULIAN | Director,TenPercentOwner | 2012-01-13 | Purchase | 72,978.0 | $16.58 |
| BAKER FELIX | Director,TenPercentOwner | 2012-01-13 | Purchase | 72,978.0 | $16.58 |
| Baker Brothers Life Sciences Capital (GP), LLC | Director,TenPercentOwner | 2012-01-13 | Purchase | 72,978.0 | $16.58 |
| BAKER JULIAN | Director,TenPercentOwner | 2012-01-13 | Purchase | 102,856.0 | $16.46 |